Expression of concern: potential risk for developing severe COVID-19 disease among anabolic steroid users
Open Access
- 26 February 2021
- journal article
- retracted article
- Published by BMJ in BMJ Case Reports
- Vol. 14 (2) , e241572
Abstract
This article has been retracted.Keywords
This publication has 26 references indexed in Scilit:
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease InhibitorCell, 2020
- Inter-correlations Among Clinical, Metabolic, and Biochemical Parameters and Their Predictive Value in Healthy and Overtrained Male Athletes: The EROS-CORRELATIONS StudyFrontiers in Endocrinology, 2019
- Enhancement of hypothalamic-pituitary activity in male athletes: evidence of a novel hormonal mechanism of physical conditioningBMC Endocrine Disorders, 2019
- Novel causes and consequences of overtraining syndrome: the EROS-DISRUPTORS studyBMC Sports Science, Medicine and Rehabilitation, 2019
- Basal Hormones and Biochemical Markers as Predictors of Overtraining Syndrome in Male Athletes: The EROS-BASAL StudyJournal of Athletic Training, 2019
- Novel insights of overtraining syndrome discovered from the EROS studyBMJ Open Sport & Exercise Medicine, 2019
- Severe rhinovirus pneumonia in a young woman taking performance-enhancing drugsBMJ Case Reports, 2016
- Bodybuilders pneumoniaJournal of Family Medicine and Primary Care, 2016
- Abstract 614: Proxalutamide (GT0918), a potent androgen receptor pathway inhibitorCancer Research, 2014
- Emerging medication for the treatment of male hypogonadismExpert Opinion on Emerging Drugs, 2012